Status:

COMPLETED

Acceptability and Tolerance Study of Peptide Feed with Fibre

Lead Sponsor:

Société des Produits Nestlé (SPN)

Conditions:

Dietary Exposure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Enterally fed adults with documented evidence of gastrointestinal intolerance will be recruited. Participants will be deemed by the investigator as having a clinical indication for enteral feeding wit...

Detailed Description

To evaluate the acceptability (including gastrointestinal tolerance and compliance) of an adult enteral peptide formula containing Partially Hydrolysed Guar Gum (PHGG) fibre in 15 patients. This is a ...

Eligibility Criteria

Inclusion

  • Enterally fed adults feeding taking ≥60% of nutritional requirements from enteral nutrition
  • Patients with documented evidence of feeding intolerance or GI symptoms during enteral feeding, and who in the clinical judgement of the supervising dietitian may benefit from a peptide formula with fibre.
  • Aged 18 years and above.
  • Willingly given, written, informed consent from patient

Exclusion

  • Inability to comply with the study protocol, in the opinion of the investigator
  • Patients receiving mechanical ventilation, sedation or inotropic support
  • Patients on total parenteral nutrition
  • Known food allergies to any ingredients (see ingredients list) or galactosaemia
  • Patients with significant renal or hepatic impairment
  • Patients with planned changes to medication or treatments during the study period which may alter gastrointestinal function (e.g. chemotherapy). Changes in medications or nutritional products during the study intervention must be documented.
  • Participation in another interventional study within 2 weeks of this study.
  • Patients with a clinical indication for a low fibre or fibre free diet as advised by the healthcare team.
  • Patients with known or suspected ileus or mechanical bowel obstruction.

Key Trial Info

Start Date :

September 5 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 3 2024

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06102135

Start Date

September 5 2023

End Date

September 3 2024

Last Update

September 23 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Nutrition and Dietetics

Liverpool, United Kingdom

2

Nutrition and Dietetics

Newcastle, United Kingdom